Salt Lake City, Utah – 2026 – USANA Health Sciences (NYSE: USNA), a global leader in direct selling and nutritional supplements, announced financial results for its fiscal fourth quarter and full year ended January 3, 2026.
Chairman and CEO Kevin Guest commented:
“USANA delivered fourth quarter net sales in line with our preliminary results announced earlier in January. We began to see signs of stabilization in active customer counts in our core nutritional business, with modest sequential growth led by mainland China, the United States, and Canada. Meanwhile, our omnichannel brands, Hiya and Rise, posted solid year-over-year growth.”
Q4 pretax earnings totaled $4.0 million, with income tax expense of $5.8 million. The tax expense included one-time impairment and cost realignment charges that impacted net earnings.
Despite reporting a net loss, adjusted metrics reflected operational stability, and adjusted EBITDA nearly doubled sequentially.
Â
Â
Â
Â
Â
Foreign exchange had a modest negative impact of approximately $3 million for the year.
Guest noted that fiscal 2025 growth was largely driven by a full-year contribution from Hiya, while core nutritional sales declined 8% amid challenging customer acquisition conditions in key markets.
USANA provided the following guidance for fiscal 2026:
The company expects continued expansion of its omnichannel business while stabilizing and modernizing its core nutritional operations.
Guest added:
“Our diversification strategy is designed to support growth beyond our core nutritional business and modernize USANA for today’s evolving marketplace. We expect our non-core brands to account for more than 20% of consolidated net sales in fiscal 2026.”
With signs of stabilization in key markets and accelerating omnichannel growth, USANA is positioning itself for a balanced approach to expansion in 2026.
Get more information
There are no reviews yet. Be the first one to write one.
